SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-17-000013
Filing Date
2017-03-06
Accepted
2017-03-06 16:53:45
Documents
3
Period of Report
2017-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnca_3-6x2017x8k.htm 8-K 31033
2 EXHIBIT 99.1 gnca_ex991xhowardmayerpres.htm EX-99.1 15691
3 gncalogoa04.jpg GRAPHIC 9090
  Complete submission text file 0001457612-17-000013.txt   60648
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 17668542
SIC: 2836 Biological Products, (No Diagnostic Substances)